Andrew Jefferson | MBABoard Director

    Andrew is an Operating Partner at Versant Ventures and has been the Chief Operating Officer at Ridgeline Discovery since 2018. Ridgeline is Versant’s Discovery Engine which creates and operates Versant-financed innovative biotech companies in Basel, Switzerland. 

    Andrew joined F. Hoffmann-La Roche in 2001 in Basel and held a wide variety of roles in Global Business and Business Development including Basel Site Head for Roche Pharma Partnering and VP Business Development at Roche Molecular Solutions in Pleasanton, CA. In this role he led the BD and Alliance Management team which successfully executed and integrated >75 deals, including 10 acquisitions. 

    He began his career in pharmaceutical manufacturing and then moved into pharma business at Ciba-Geigy and Novartis in the UK. He received his BSc in Chemistry from the University of Nottingham and an MBA from the University of Brighton.

    error: Content is protected !!!